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It has been shown that a C-terminally truncated form of the middle-sized hepatitis B virus (HBV) surface protein (MHBst)
functions as a transcriptional activator. This function is dependent on the cytosolic orientation of the N-terminal PreS2
domain of MHBst, but in the case of wild-type MHBs, the PreS2 domain is cotranslationally translocated into the ER lumen.
Recent reports demonstrated that the PreS2 domain of the large HBV surface protein (LHBs) initially remains on the cytosolic
side of the ER membrane after translation. Therefore, the question arose as to whether the LHBs protein exhibits the same
transcriptional activator function as MHBst. We show that LHBs, like MHBst, is indeed able to activate a variety of promoter
elements. There is evidence for a PKC-dependent activation of AP-1 and NF-kB by LHBs. Downstream of the PKC the
functionality of c-Raf-1 kinase is a prerequisite for LHBs-dependent activation of AP-1 and NF-kB since inhibition of c-Raf-
1 kinase abolishes LHBs-dependent transcriptional activation of AP-1 and NF-kB. q 1996 Academic Press, Inc.
The gene for the HBV surface antigen consists of a PreS2 domain of a fraction of LHBs is found on the viral
surface.single ORF divided into three coding regions, preS1,
preS2, and S, each starting with an in-frame ATG codon. Whereas MHBs and SHBs are secreted as subviral
particles, the secretion of LHBs requires coexpressionThe corresponding protein domains are therefore re-
ferred to as PreS1, PreS2, and S. By translational initia- of the MHBs and SHBs. A strong overproduction of LHBs
with respect to MHBs and SHBs causes the intracellulartion at the first AUG the large hepatitis surface antigen
(LHBs) encompassing PreS1, PreS2, and S is synthe- retention of all proteins (4–6). In the case of 3* terminal
truncations of the preS2/S gene—at least the codingsized; by initiation at the second AUG the middle surface
protein (MHBs, encompassing PreS2 / S), and by initia- region for the transmembrane region 3 has to be de-
leted—the resulting MHBs derivative gains a transcrip-tion at the third, the small surface protein (SHBs, encom-
passing S) is synthesized. All three HBV surface proteins tional activator function (7–9). In contrast to full-length
MHBs, the transcriptional activators are not secreted andare integral membrane proteins. MHBs occurs in a mono-
or biglycosylated form. Glycan residues are linked at aa not glycosylated (10).
In a recent report (11) it was demonstrated that the4 of the PreS2 region and at aa 146 of the S region. LHBs
and SHBs are monoglycosylated; the glycan residue is PreS2 region is sufficient for generation of the transcrip-
tional activator function. It was shown that the reason forlinked to aa 146 of the S region. Surprisingly, LHBs is
monoglycosylated although it harbors a second glycosyl- the functional difference between the structural protein
MHBs and the transcriptional MHBst activators is a differ-ation site at aa 4 of the PreS2 region. Recent work, how-
ever, revealed that in the case of LHBs the PreS1–PreS2 ence in the localization of the amino-terminal PreS2 re-
gion. In the case of MHBs this domain is oriented towardregion is not cotranslationally translocated across the
ER membrane and therefore is oriented toward the cyto- the lumen of the ER (10, 12), whereas in the case of
functional MHBst activators this region faces the cyto-plasm (1 – 3). This orientation makes the glycosylation
site at asn 4 of the PreS2 region inaccessible to the plasm (11). This orientation apparently makes an interac-
tion with cytosolic binding partners possible. A directglycosyltransferases, which are localized in the lumen of
the ER. Only in a fraction of the LHBs chains does the interaction with PKC was shown to be essential for trig-
gering the MHBst-dependent transcriptional activationPreS1–PreS2 region seem to be posttranslationally
translocated across the membrane in the secretory path- (Hildt et al., submitted for publication).
Since LHBs shares with MHBst activators a cytoplasmicway during viral assembly. In the viral particle the Pres1–
orientation of the PreS2 domain, we investigated whether
LHBs displays a transcriptional activator function like1 To whom correspondence and reprint requests should be ad-
dressed. MHBst. HepG2 cells (1.0 1 106 cells) were cotransfected
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with 1.5 mg of the LHBs expression plasmid pSVLM0S0 The functionality of c-Raf-1 kinase is essential for trig-
gering the activation of AP-1 and NF-kB in MHBst-produc-(13) and the reporter constructs pSV2-CAT (0.5 mg), p3xAP-
1-CAT (1 mg), or p2xNF-kB-CAT (1.5 mg). The vector ing cells (Hildt et al., submitted for publication). To inves-
tigate whether the LHBs-dependent transcriptional acti-pSVLM0S0 directs the production of the LHBs protein in
the absence of MHBs and SHBs and allows a characteriza- vation of AP-1 and NF-kB is also mediated by an
activation of c-Raf-1 kinase, 1.0 1 106 HepG2-cells weretion of LHBs-dependent transcriptional activation without
the influence of other HBV proteins. Upon cotransfection transfected with 1.5 mg of the expression plasmid
pSVLM0S0, the reporter constructs p3xAP-1-CAT (1 mg)with the expression vector pSVLM0S0 and each of the
reporter constructs, a seven- to ninefold induction of the or p2xNF-kB-CAT (1.5 mg), respectively, and 1.5 mg of the
plasmid pHCR13.1 (14), which encodes a transdominantCAT reporter gene was observed. This induction is compa-
rable to the transcriptional activation following transfection negative mutant of c-Raf-1 kinase. Coexpression of the
transdominant negative mutant caused a complete losswith the expression plasmid pSVMHBst76, which encodes
a MHBst protein truncated at aa 76 (10). As a negative of the LHBs-dependent activation of AP-1 (1.7-fold) or
NF-kB (1.4-fold), respectively (Fig. 2b). The MHBst76-de-control cotransfection with an equal amount of pUC 19
was performed (Fig. 1a). In all transfection experiments pendent activation of these transcription factors, which
was used as a positive control, was also completely abol-transfection efficiencies were standardized with a lucifer-
ase reporter construct containing the luciferase gene under ished. In the control experiments the plasmid pHCR13.1
was replaced by an equal amount (1.5 mg) of the cloningcontrol of the nonstimulatable minimal promoter pTK/-37luc.
Various minimal promoters (2xNF-kB or 3xAP-1) or the vector pMNC. Under these conditions the already de-
scribed (Fig. 1) activation of both transcription factors bySV40 early promoter were activated by the production of
LHBs. This indicates that the structure protein LHBs is LHBs or MHBst76 was observed. To demonstrate that the
inhibition of the LHBs-dependent activation of AP-1 ora pleiotropic transcriptional activator.
The question thus arose as to whether L proteins, in NF-kB is not due to nonspecific toxicity caused by the
construct pHCR13.1, cells were cotransfected withthe presence of MHBs and SHBs, also serve as transcrip-
tional activators. Therefore, HepG2 cells were cotrans- pHCR13.1 and the reporter plasmid p2xNF-kB-CAT. The
cells were stimulated by the addition of H2O2 to a finalfected with the reporter constructs described above and
expression vector pSVLHBs (1), leading to the production concentration of 500 mM. The H2O2-dependent activation
of NF-kB was not affected by the coexpression of theof LHBs, MHBs, and SHBs. Compared to the cotransfec-
tion of cells with pSVLM-S-, a slightly reduced, but still transdominant negative mutant of c-Raf-1 compared to
control-transfected cells (data not shown). These experi-six- to sevenfold transcriptional activation was observed
(Fig. 1b). The slight reduction might reflect a reduced ments clearly demonstrate that the LHBs-dependent
transcriptional activation is mediated by c-Raf-1 kinase.synthesis of LHBs.
The MHBst-dependent transcriptional activation was However, elevation of the endogenous c-Raf-1-kinase
level by transfection of the cells with the c-Raf-1 kinaseshown to be mediated by PKC-dependent activation of
the c-Raf-1/MAP2-kinase signal transduction pathway expression plasmid pMNC-c-raf instead of pHCR13.1 did
not cause a significant increase in the LHBs- or MHBst76-(Hildt et al., submitted). To study whether the LHBs-de-
pendent transcriptional activation is also triggered by the dependent activation of the reporter constructs. It can be
concluded that the endogenous level of c-Raf-1 kinasesame signaling pathway, the cotransfection experiments
described were first performed in the presence of the is not limiting for triggering LHBs-dependent activation
of AP-1 or NF-kB.PKC inhibitor H7. The LHBs-dependent activation of the
reporter constructs p3xAP-1-CAT or p2xNF-kB-CAT was Altogether, in this study we have demonstrated that
LHBs is indeed a functional activator. Furthermore, wecompletely abolished by the presence of 0.1 mM H7 in
the culture fluid (Fig. 2a). Inhibition of the MHBst76-depen- found that the mechanism of LHBs-dependent transcrip-
tional activation is mediated by PKC-dependent activa-dent activation of these reporter constructs as demon-
strated earlier (Hildt et al., submitted for publication) was tion of the c-Raf/MAP-kinase signal transduction path-
way, which is also used in the case of MHBst-dependentalso observed. Transfection of cells with the cloning vec-
tor pUC19 served as the negative control. Since H7 dis- transcriptional activation. Identical targets, i.e., AP-1 or
NF-kB, are activated, and in both cases the PKC seemsplays no absolute PKC specificity, the PKC was depleted
by continuous TPA stimulation (100 ng/ml) 30 hr prior to to be essential for triggering the transcriptional activation
as well as c-Raf-1 kinase. Therefore, we conclude thattransfection. Under these conditions the LHBs-depen-
dent as well as the MHBst76-dependent activation of the the transcriptional activator function of LHBs is gener-
ated by the cytoplasmic orientation of its PreS2 region.NF-kB- (7-fold of the control) and the AP-1-driven (9-fold
of the control) reporter constructs was abolished (1.3- to The observed transcriptional activation appears not
to be caused by the ER retention of LHBs resulting in1.5-fold of the control). These results suggest that the
LHBs-dependent transcriptional activation could be me- generation of an increased level of intracellular radicals.
Cotransfection experiments in the presence of 30 mMdiated by an activation of the PKC (Fig. 2a).
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FIG. 1. LHBs has a transcriptional activator function. (a) CAT assay after cotransfection of HepG2 cells with the reporter plasmid pSV2-CAT,
p3xAP-1-CAT, or p2xNF-kB-CAT and the expression plasmid pSVLM-S- (encoding for LHBs), pSVMHBst76 (encoding for MHBst76), or pUC19 as the
negative control. Fold inductions are the mean values from four independent transfection experiments, calculated as the values for the vector
control. (b) CAT assay after cotransfection of HepG2 cells with the reporter plasmid pSV2-CAT, p3xAP-1-CAT, or p2xNF-kB-CAT and the expression
plasmid pSVLHBs (encoding for LHBs, MHBs, and SHBs), pSVMHBst76, or pUC19 as the negative control. Fold inductions are the mean values from
four independent transfection experiments, calculated as the values for the vector control.
N-acetyl-L-cysteine demonstrated that under these con- these conditions. Since overproduction of LHBs results
in the activation of several kinases (PKC, c-Raf-1 kinase)ditions no significant influence on the transcriptional acti-
vator function could be observed (data not shown). triggering cellular proliferation control, it is possible that
continuous activation of these enzymes might addition-Continuous overproduction of LHBs results in vivo in
the generation of ground glass hepatocytes in transgenic ally contribute to the development of a hepatocellular
carcinoma. According to a multifactorial model of carci-mice (5), which are characterized by large amounts of
intracellular LHBs. In a transgenic mouse model the pro- nogenesis, the continuous expression of LHBs might
have a tumor promoter function.duction of HCC was observed under these conditions
(5). The development of HCC was considered so far to LHBs is essential for the assembly of viral particles. On
the basis of our results, we propose that a second functionbe caused by a permanent inflammatory process under
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FIG. 2. Transcriptional activator function of LHBs depends on PKC and c-Raf-1 kinase. CAT assay after cotransfection of HepG2 cells with pSVLM-
S- and the reporter constructs p3xAP-1-CAT or p2xNF-kB-CAT. Cotransfection of the cells with pSVMHBst76 served as a positive control, cotransfection
with pUC19 as a negative control. Fold inductions are the mean values from four independent transfection experiments, calculated as the values
for the vector control. (a) Cells were grown in the presence of 0.1 mM H7 in the culture fluid to inhibit PKC, or PKC was depleted by exposure of
the cells to 200 ng/ml TPA 30 hr prior to transfection. (b) Cells were cotransfected with pHCR13.1, which encodes a transdominant negative mutant
of c-Raf-1 kinase, pSVL M0S0, or pSVMHBst76 and the reporter constructs p2xNF-kB-CAT or p3xAP-1-CAT. In the control experiments cells were
cotransfected with the cloning vector pMNC instead of pSVL M0S0 or pSVMHBst76.
of LHBs is to support viral replication by a transcriptional HBx, at least in vitro, seems to be dispensable for HBV
replication. It should also be noted that the reported find-activation of the viral promoter elements. This appears to
be parallel to HBx, whose function does not appear to be ings link the transcriptional activator function of LHBs to
the increased risk of HBs carriers of developing HCC, sincea prerequisite for HBV replication. However, the presence
of HBx appears to support the viral replication (15) by a these carriers are also LHBs-positive.
transcriptional activation of viral and/or cellular promoters.
In particular, immediately upon infection of hepatocytes,
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